Provided by Tiger Trade Technology Pte. Ltd.

Corcept Therapeutics

37.60
-0.9300-2.41%
Post-market: 37.38-0.2249-0.60%19:51 EDT
Volume:1.78M
Turnover:67.11M
Market Cap:4.00B
PE:45.85
High:38.44
Open:38.09
Low:37.15
Close:38.53
52wk High:117.33
52wk Low:28.66
Shares:106.37M
Float Shares:86.88M
Volume Ratio:0.43
T/O Rate:2.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.8200
EPS(LYR):0.8200
ROE:15.01%
ROA:3.34%
PB:6.17
PE(LYR):45.85

Loading ...

Corcept Chief Development Officer William Guyer disposes of USD 423,000 in common shares

Reuters
·
Mar 25

A Look At Corcept Therapeutics (CORT) Valuation As Shares Trade Below Popular Fair Value Estimates

Simply Wall St.
·
Mar 24

Analysts’ Opinions Are Mixed on These NA Stocks: Corcept Therapeutics (CORT) and Fiserv (FISV)

TIPRANKS
·
Mar 23

Corcept Therapeutics Director G. Leonard Baker Jr acquires USD 3.31 million in common shares

Reuters
·
Mar 20

Corcept faces class action over relacorilant NDA claims after 50.4% stock drop

Reuters
·
Mar 19

Class action lawsuit targets Corcept Therapeutics over alleged securities law violations

Reuters
·
Mar 18

Wolf Haldenstein files securities class action against Corcept Therapeutics over relacorilant statements

Reuters
·
Mar 16

Corcept Therapeutics (CORT) Is Down 5.1% After FDA Relacorilant Rejection And Investor Lawsuits - What's Changed

Simply Wall St.
·
Mar 15

Corcept Chief Development Officer William Guyer Disposes of Common Shares

Reuters
·
Mar 07

Corcept Investors Face April 21 Lead Plaintiff Deadline in Securities Fraud Class Action

Reuters
·
Mar 06

Hagens Berman Files Securities Class Action Against Corcept Therapeutics

Reuters
·
Mar 05

Canaccord Genuity Sticks to Its Buy Rating for Corcept Therapeutics (CORT)

TIPRANKS
·
Mar 04

Pomerantz Files Class Action Lawsuit Against Corcept Therapeutics

Reuters
·
Mar 04

Stock Track | Corcept Therapeutics Plummets 5.06% Intraday Following Securities Fraud Class Action Filing

Stock Track
·
Mar 04

Rosen Law Firm Files Securities Class Action Against Corcept Therapeutics

Reuters
·
Mar 03

Rosen Law Firm Urges Corcept Investors to Seek Counsel Before April 21 Lead Plaintiff Deadline

Reuters
·
Feb 28

Portnoy Law Firm Files Class Action Against Corcept Therapeutics

Reuters
·
Feb 27

Robbins LLP Alerts Corcept Investors to Lead Plaintiff Deadline in Class Action Lawsuit

Reuters
·
Feb 26

Lead Plaintiff Deadline Set in Corcept Therapeutics Securities Class Action

Reuters
·
Feb 26

Stock Track | Corcept Therapeutics Plummets 5.15% Intraday Following Analyst Price Target Cuts

Stock Track
·
Feb 26